GRA12D

GRA12D is a Toxoplasma gondii dense granule protein expressed across both the acute (tachyzoite) and chronic (bradyzoite) asexual stages that contributes to chronic-stage cyst biology (PMID:33883265). In tachyzoites it colocalizes with dense granules in extracellular parasites and with GRA2 and the intravacuolar network within the parasitophorous vacuole, and in bradyzoites it is secreted and incorporated into the developing cyst wall and cyst matrix (PMID:33883265). Functionally, GRA12D is dispensable for acute virulence but is required for efficient cyst reactivation: deletion reduces in vitro reactivation efficiency, placing GRA12D in the chronic-to-recrudescent transition rather than acute infection (PMID:33883265). Beyond this localization and knockout phenotype, no molecular activity, binding partner, or biochemical mechanism for GRA12D has been characterized in the available corpus.

1. 2021 Medium

   Establishing where and when GRA12D acts was the first step: it defined GRA12D as a stage-spanning dense granule protein that transitions from the tachyzoite intravacuolar network to the bradyzoite cyst wall and matrix.

   Evidence Fluorescence microscopy/colocalization with dense granules, GRA2, and the intravacuolar network, plus stage-specific expression and secretion analysis in Toxoplasma gondii

   PMID:33883265

   Open questions at the time

   • No molecular partners or binding interactions within the intravacuolar network or cyst wall identified
   • Mechanism of secretion and incorporation into the cyst matrix not defined
   • No biochemical or enzymatic activity assigned
2. 2021 Medium

   Genetic ablation tested whether GRA12D is functionally required, revealing a stage-restricted role: it is dispensable for acute virulence but needed for efficient chronic cyst reactivation.

   Evidence Gene knockout (Δgra12D) assessed by mouse acute virulence infection and in vitro cyst reactivation assay in Toxoplasma gondii

   PMID:33883265

   Open questions at the time

   • Molecular mechanism linking GRA12D to reactivation efficiency unknown
   • Single lab, in vitro reactivation readout without in vivo reactivation confirmation
   • Whether the cyst-wall/matrix localization mediates the reactivation phenotype is untested

• The molecular function of GRA12D — its binding partners, biochemical activity, and the mechanism by which its cyst-wall localization drives reactivation — remains undefined.
• No interactome or structural data
• No defined molecular activity
• Causal link between cyst-matrix incorporation and reactivation not established